Mercado de bronquiectasias en América del Norte: tendencias de la industria y pronóstico hasta 2028

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Pharmaceutical North America Bronchiectasis Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado de bronquiectasias en América del Norte: tendencias de la industria y pronóstico hasta 2028

  • Pharmaceutical
  • Published Report
  • Sep 2021
  • North America
  • 350 Páginas
  • Número de tablas: 119
  • Número de figuras: 50
Comprar ahoraComprar ahora

>Mercado de bronquiectasia en América del Norte, por tipo de enfermedad (bronquiectasia con fibrosis quística y bronquiectasia sin fibrosis quística), gravedad (leve a moderada y moderada a grave), tipo (diagnóstico y tratamiento), tipo de fármaco (de marca y genéricos ), vía de administración (oral, parenteral e inhalación), usuario final (hospitales, clínicas, atención médica domiciliaria y otros), canal de distribución (farmacia hospitalaria, farmacia minorista , farmacia en línea, otros), país (EE. UU., Canadá, México), tendencias de la industria y pronóstico de 2021 a 2028.

Mercado de bronquiectasias en América del Norte

Análisis y perspectivas del mercado : mercado de bronquiectasias en América del Norte

Se espera que el mercado de bronquiectasias de América del Norte gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 6,1% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 396,93 millones para 2028. Un aumento en la investigación sobre la enfermedad de bronquiectasias y la disponibilidad de medicamentos genéricos en países subdesarrollados y en desarrollo son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.

La bronquiectasia incluye características tales como la creciente necesidad de un producto seguro y eficaz que tendrá un impacto en el lanzamiento de nuevas creaciones por parte de los fabricantes al mercado, lo que aumentará su demanda, así como el aumento de la inversión en investigación y desarrollo que conduce al crecimiento del mercado. Actualmente, se están llevando a cabo varios estudios de investigación que se espera que creen una ventaja competitiva para que los fabricantes desarrollen productos nuevos e innovadores para la bronquiectasia, lo que se espera que brinde varias otras oportunidades en el mercado de la bronquiectasia. Sin embargo, se espera que las complicaciones en el tratamiento de la bronquiectasia y los desafíos de diagnóstico limiten el crecimiento del mercado en el período de pronóstico.

El informe de mercado de Bronquiectasias proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado , aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.

Mercado de bronquiectasias en América del NorteAlcance y tamaño del mercado de la bronquiectasia en América del Norte

El mercado de la bronquiectasia está segmentado en función del tipo de enfermedad, la gravedad, el tipo, el tipo de fármaco, la vía de administración, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.

  • Según el tipo de enfermedad, el mercado de la bronquiectasia se segmenta en bronquiectasias con fibrosis quística y bronquiectasias sin fibrosis quística. En 2021, se espera que la bronquiectasia sin fibrosis quística domine el mercado de la bronquiectasia, ya que es una forma de bronquiectasia muy prevalente y se notifican más casos entre las mujeres y la población de mayor edad. 
  • En función de la gravedad, el mercado de bronquiectasias de América del Norte se segmenta en leve a moderada y moderada a grave. En 2021, se espera que el segmento leve a moderado domine el mercado de bronquiectasias porque al inicio de la bronquiectasia, los pacientes experimentan tos leve , obstrucción de las vías respiratorias, entre otros síntomas que persisten de por vida. 
  • Según el tipo, el mercado de la bronquiectasia se segmenta en diagnóstico y tratamiento. En 2021, se espera que el segmento de tratamiento domine el mercado de la bronquiectasia porque la bronquiectasia es una enfermedad crónica que dura toda la vida. La gravedad de la enfermedad aumenta con la edad y, por lo tanto, la población afectada depende de enfoques de tratamiento efectivos.
  • Según el tipo de medicamento, el mercado de la bronquiectasia se segmenta en medicamentos de marca y genéricos. En 2021, se espera que el segmento de marca domine el mercado de la bronquiectasia porque los productos que ofrecen las numerosas empresas son fórmulas patentadas y los pacientes están cada vez más seguros de las fórmulas de marca.
  • Según la vía de administración, el mercado de la bronquiectasia se segmenta en oral, parenteral e inhalatoria. En 2021, se espera que el segmento de inhalación domine el mercado de la bronquiectasia debido a la alta tasa de eficacia de la formulación de medicamentos inhalatorios para el tratamiento de enfermedades respiratorias. Además, el aumento de la innovación para el desarrollo de inhaladores inteligentes equipados con regulación de la dosis de medicamentos es otro factor que impulsa el crecimiento del mercado.
  • En función del usuario final, el mercado de la bronquiectasia se segmenta en hospitales, clínicas, atención médica domiciliaria y otros. En 2021, el segmento de hospitales domina el mercado de la bronquiectasia porque la mayoría de los pacientes que la padecen visitan los hospitales para obtener un diagnóstico preciso de la enfermedad y experimentar un tratamiento eficaz con profesionales especializados.
  • Según el canal de distribución, el mercado de la bronquiectasia se segmenta en farmacias hospitalarias, farmacias minoristas, farmacias en línea y otras. En 2021, se espera que las farmacias hospitalarias dominen el mercado de la bronquiectasia, ya que ofrecen una amplia gama de medicamentos y terapias junto con una consulta adecuada y reconocimiento de marca.

Mercado de bronquiectasias en América del NorteAnálisis del mercado de bronquiectasias a nivel de país

Se analiza el mercado de bronquiectasias y se proporciona información sobre el tamaño del mercado en función del tipo de enfermedad, la gravedad, el tipo, el tipo de medicamento, la vía de administración, el usuario final y el canal de distribución.

Los países cubiertos en el informe del mercado de bronquiectasias son EE. UU., Canadá y México.

Mild to moderate segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing clinical trials and research development for prevention of respiratory diseases among the adults. U.S. is leading the growth of the North America market and Mild to moderate segment is dominating in this country because Bronchiectasis is a chronic, progressive and recurrent pulmonary infections these symptoms causes severe issues in patient day to day life. So, these symptoms seen in the initial stage of the bronchiectasis and treatment can be done on initial stage. Canada is expected to grow in the market due to rising government initiatives for treatment of rare diseases moreover Mexico is attaining lucrative growth due to rising cases of respiratory diseases and increase in awareness towards the better treatment options.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Awareness for Prevention of Bronchiectasis and Increasing Healthcare Expenditure are Boosting the Market Growth of Bronchiectasis

Bronchiectasis market also provides you with detailed market analysis for every country growth in Bronchiectasis industry with Bronchiectasis drugs sales, impact of advancement in the Bronchiectasis technology and changes in regulatory scenarios with their support for the Bronchiectasis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Bronchiectasis Market Share Analysis

Bronchiectasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Bronchiectasis market.

Las principales empresas que se dedican al tratamiento de la bronquiectasia son Abbott, HERSILL, Home Oxygen Company, Inogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc, Ache Laboratories Farmaceuticos SA, Horizon Therapeutics plc, Janssen Pharmaceuticals, Inc. (una subsidiaria de Johnson & Johnson Services, Inc.), Trudell Medical International, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Novartis AG, Teva Pharmaceutical USA Inc. (una subsidiaria de Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Bayer AG, Dr. Reddy's Laboratories Ltd., Sunovion Pharmaceuticals Inc. (una subsidiaria de Sumitomo Dainippon Pharma Co., Ltd.), Viatris Inc., Zydus Pharmaceuticals, Inc. (una subsidiaria de Zydus Cadila), Cipla Inc., Electromed, Inc., entre otros.

Muchos lanzamientos de productos y acuerdos también son iniciados por empresas de todo el mundo, lo que también está acelerando el mercado de la bronquiectasia.

Por ejemplo,

  • En junio de 2019, AstraZeneca recibió la aprobación para Breztri Aerosphere (PT010), compuesto de budesonida/glicopirronio/fumarato de formoterol, en Japón. El producto se utiliza ampliamente para el tratamiento de la inflamación asociada a los pulmones. Esta aprobación permitió a la empresa obtener ventas constantes y aumentar los ingresos de la empresa.
  • En marzo de 2019, Novartis AG lanzó Ultibro Breezhaler y Seebri Breezhaler (inhaladores para la EPOC), que han demostrado ser eficaces para el tratamiento de enfermedades respiratorias inflamatorias e infecciosas. Esta iniciativa impulsó la cartera de productos de la empresa y le permitió ampliar su presencia en el mercado de la bronquiectasia.

La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias del actor del mercado están mejorando el mercado de la empresa en el mercado de bronquiectasias, lo que también brinda el beneficio a la organización de mejorar su oferta para bronquiectasias.

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of North America bronchiectasis market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. disease type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drugs type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. Pipeline analysis
  6. North America bronchiectasis market: Laws and regulations
  7. Epidemiology
  8. Market Overview
    1. Drivers
      1. Rising Patient Population Suffering from bronchiectasis
      2. growing geriatric population
      3. rising number of smokers and consumption of alcohol
      4. technological advancement for disease testing
      5. growing DIAGNOSTIC rate
    2. restrainTs
      1. high cost of diagnostic tools
      2. product recalls
      3. inappropriate reimbursement policies
    3. opportunities
      1. Rising awareness for prevention of bronchiectasis in primary and secondary care
      2. increasing healthcare expenditure
      3. increase in research regarding the bronchiectasis disease
    4. challenges
      1. complications in the treatment of bronchiectasis
      2. lack of skilled professionals
      3. diagnositic challenges
  9. IMPACT OF COVID-19
    1. PRICE IMPACT
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. North America bronchiectasis market, BY disease type
    1. overview
    2. Non-CF Bronchiectasis
    3. CF Bronchiectasis
  11. North America bronchiectasis market, BY severity
    1. overview
    2. mild to moderate
    3. moderate to severe
  12. North America bronchiectasis market, BY type
    1. overview
    2. treatment
      1. Antibiotics
        1. MACROLIDE
          1. AZITHROMYCIN
          2. CLARITHROMYCIN
          3. OTHERS
        2. AMOXICILLIN
        3. CEPHALOSPORIN
          1. SECOND-GENERATION CEPHALOSPORIN
          2. THIRD-GENERATION CEPHALOSPORIN
        4. AMINOGLYCOSIDE
          1. GENTAMICIN
          2. TOBRAMYCIN
        5. FLUOROQUINOLONE
        6. TETRACYCLINS
        7. TRIMETHOPRIM-SULFAMETHOXAZOLE
        8. COMBINATION THERAPY
      2. Corticosteroids
        1. BUDESONIDE
        2. FLUTICASONE
        3. MOMETASONE
        4. FLUNISOLIDE
        5. OTHERS
      3. Bronchodilators
        1. LONG-ACTING BRONCHODILATORS
          1. FORMOTEROL
          2. TIOTROPIUM
          3. SALMETEROL
          4. OTHERS
        2. SHORT-ACTING BRONCHODILATORS
          1. ALBUTEROL
          2. LEVALBUTEROL
          3. OTHERS
      4. Mucus Thinning Medicine
        1. CARBOCISTEINE
        2. BROMHEXINE
        3. OTHERS
      5. Airway Clearance Devices
        1. OSCILLATING POSITIVE EXPIRATORY PRESSURE (PEP)
        2. INTRAPULMONARY PERCUSSIVE VENTILATION (IPV)
        3. POSTURAL DRAINAGE
        4. OTHERS
      6. Oxygen Therapy
        1. OXYGEN CONCENTRATORS
        2. COMPRESSED GAS OXYGEN
        3. LIQUID OXYGEN
      7. Surgery
        1. BRONCHOSCOPY
        2. LUNG TRANSPLANT
      8. Others
    3. diagnosis
      1. Chest CT Scan
      2. Sputum Test
      3. Pulmonary Function Test
      4. X-Ray
      5. Others
  13. North America bronchiectasis market, BY drugs type
    1. overview
    2. branded
    3. generics
  14. North America bronchiectasis market, BY route of administration
    1. overview
    2. inhalation
    3. oral
      1. Tablets
      2. Capsules
      3. Others
    4. parenteral
      1. Intravenous
      2. Subcutaneous
      3. Others
  15. North America bronchiectasis market, BY end user
    1. overview
    2. hospitals
    3. clinics
    4. home healthcare
    5. others
  16. North America bronchiectasis market, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online pharmacy
    5. others
  17. North America bronchiectasis market by region
    1. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
  18. North America bronchiectasis market: COMPANY landscape
    1. company share analysis: north america
  19. SWOT
  20. Company profiles
    1. AstraZeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Merck Sharp & Dohme Corp. (A subsidiary of Merck & Co., Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Ache Laboratories Farmaceuticos S.A.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Bayer AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. boehringer ingelheim international gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Cipla Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Electromed, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. hersill
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. home oxygen company
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. horizon therapeutics plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. inogen, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    18. medline industries, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. Pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. Sunovion Pharmaceuticals Inc. (A Subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    22. truedell medical international
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    23. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

Lista de Tablas

TABLE 1 North America bronchiectasis market, pipeline analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Healthcare expenditure in north america per capita (usd)

TABLE 4 THE PRICE OF X-RAY MACHINE

TABLE 5 North America bronchiectasis market, By Disease Type, 2019-2028 (USD Million)

TABLE 6 North America bronchiectasis market, By Severity, 2019-2028 (USD Million)

TABLE 7 North America bronchiectasis market, By Type, 2019-2028 (USD Million)

TABLE 8 north america Treatment by Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 9 north america Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 10 north america Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 11 north america Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 12 north america Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 13 north america Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 14 north america Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 15 north america Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 16 north america Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 17 north america Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 18 north america Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 19 north america Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 20 north america Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 21 North America bronchiectasis market, By Drugs Type, 2019-2028 (USD Million)

TABLE 22 North America bronchiectasis market, By Route of Administration, 2019-2028 (USD Million)

TABLE 23 north america Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 24 north america Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 25 North America bronchiectasis market, By End User, 2019-2028 (USD Million)

TABLE 26 North America bronchiectasis market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 27 NORTH AMERICA BRONCHIECTASIS MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 28 NORTH America BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 29 NORTH America BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 30 NORTH America BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 31 NORTH America treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 32 NORTH America treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 33 North America Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 34 North America Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 35 North America Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 36 North America Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 37 North America Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 38 North America Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 39 North America Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 40 North America Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 41 North America Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 42 North America Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 43 North America Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 44 North America Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 45 North America Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 46 North America Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 47 North America Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 48 North America Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 49 NORTH America BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 50 NORTH America BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 51 U.S. BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 52 U.S. BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 53 U.S. BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 54 U.S. treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 55 U.S. treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 56 U.s. Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 57 U.S. Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 58 u.S. Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 59 u.s. Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 60 u.s. Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 61 u.s. Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 62 u.s. Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 63 u.s. Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 64 u.s. Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 65 u.s. Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 66 u.s. Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 67 u.s. Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 68 u.s. Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 69 u.s. Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 70 u.s. Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 71 u.s. Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 72 u.s. BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 73 u.s. BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 74 canada BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 75 canada BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 76 canada BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 77 canada treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 78 canada treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 79 canada Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 80 canada Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 81 canada Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 82 canada Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 83 canada Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 84 canada Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 85 canada Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 86 canada Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 87 canada Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 88 canada Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 89 canada Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 90 canada Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 91 canada Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 92 canada Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 93 canada Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 94 canada Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 95 canada BRONCHIECTASIS Market, By end user, 2019-2028 (USD Million)

TABLE 96 canada BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 97 mexico BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 98 mexico BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 99 mexico BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 100 mexico treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 101 mexico treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 102 mexico Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 103 mexico Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 104 mexico Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 105 mexico Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 106 mexico Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 107 mexico Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 108 mexico Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 109 mexico Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 110 mexico Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 111 mexico Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 112 mexico Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 113 mexico Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 114 mexico Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 115 mexico Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 116 mexico Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 117 mexico Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 118 mexico BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 119 mexico BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

Lista de figuras

FIGURE 1 North America bronchiectasis market: SEGMENTATION

FIGURE 2 NORTH AMERICA BRONCHIECTASIS MARKET : DATA TRIANGULATION

FIGURE 3 North America bronchiectasis market: DROC ANALYSIS

FIGURE 4 North America bronchiectasis market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 North America bronchiectasis market: COMPANY RESEARCH ANALYSIS

FIGURE 6 North America bronchiectasis market: MULTIVARIATE MODELLING

FIGURE 7 North America bronchiectasis market: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA BRONCHIECTASIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA BRONCHIECTASIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 North America bronchiectasis market: MARKET drugs type COVERAGE GRID

FIGURE 11 North America bronchiectasis market: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM BRONCHIECTASIS is DRIVing THE North America bronchiectasis market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 NON-CF BRONCHIECTASIS SEGMENT is expected to account for the largest share of the North America bronchiectasis market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF North America bronchiectasis market

FIGURE 15 Number of Persons Aged 60 Years Across Several Regions in 2017 and 2050

FIGURE 16 Health Spending by Major Sources of Funds

FIGURE 17 North America bronchiectasis market: BY disease type, 2021

FIGURE 18 North America bronchiectasis market: BY disease type, 2019-2028 (USD Million)

FIGURE 19 North America bronchiectasis market: BY disease type, CAGR (2021-2028)

FIGURE 20 North America bronchiectasis market: BY disease type, LIFELINE CURVE

FIGURE 21 North America bronchiectasis market: BY severity, 2021

FIGURE 22 North America bronchiectasis market: BY severity, 2019-2028 (USD Million)

FIGURE 23 North America bronchiectasis market: BY severity, CAGR(2021-2028)

FIGURE 24 North America bronchiectasis market: BY severity, LIFELINE CURVE

FIGURE 25 North America bronchiectasis market: BY type, 2021

FIGURE 26 North America bronchiectasis market: BY type, 2019-2028 (USD Million)

FIGURE 27 North America bronchiectasis market: BY type, CAGR (2021-2028)

FIGURE 28 North America bronchiectasis market: BY type, LIFELINE CURVE

FIGURE 29 North America bronchiectasis market: BY drugs type, 2021

FIGURE 30 North America bronchiectasis market: BY drugs type, 2019-2028 (USD Million)

FIGURE 31 North America bronchiectasis market: BY drugs type, CAGR (2021-2028)

FIGURE 32 North America bronchiectasis market: BY drugs type, LIFELINE CURVE

FIGURE 33 North America bronchiectasis market: BY route of administration, 2021

FIGURE 34 North America bronchiectasis market: BY route of administration, 2019-2028 (USD Million)

FIGURE 35 North America bronchiectasis market: BY route of administration, CAGR (2021-2028)

FIGURE 36 North America bronchiectasis market: BY route of administration, LIFELINE CURVE

FIGURE 37 North America bronchiectasis market: BY end user, 2021

FIGURE 38 North America bronchiectasis market: BY end user, 2019-2028 (USD Million)

FIGURE 39 North America bronchiectasis market: BY end user, CAGR (2021-2028)

FIGURE 40 North America bronchiectasis market: BY end user, LIFELINE CURVE

FIGURE 41 North America bronchiectasis market: BY distribution channel, 2021

FIGURE 42 North America bronchiectasis market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 43 North America bronchiectasis market: BY distribution channel, CAGR (2021-2028)

FIGURE 44 North America bronchiectasis market: BY distribution channel, LIFELINE CURVE

FIGURE 45 NORTH America BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 46 NORTH America BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 47 NORTH America BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 48 NORTH America BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 49 NORTH America BRONCHIECTASIS market: BY disease type (2021-2028)

FIGURE 50 North America Bronchiectasis Market: company share 2020 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Explorar páginas relacionadas

Banner